In response to infection and tissue damage, it encourages the development and activation of T-cells, B-cells, macrophages, etc. In patients who had stage 3 AKI compared to non-AKI patients, higher blood IL-6 levels were substantially associated with a higher risk of developing AKI. This evidence concerns the gene IL6 and acute kidney injury.